BNC KOREA CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,200 KRW | +0.32% |
|
+0.16% | +67.57% |
| Sales 2022 | 42.3B 30.75M 2.46B | Sales 2023 | 81B 58.89M 4.72B | Capitalization | 246B 179M 14.29B |
|---|---|---|---|---|---|
| Net income 2022 | -44.7B -32.5M -2.6B | Net income 2023 | 25.69B 18.67M 1.5B | EV / Sales 2022 | 4.78 x |
| Net cash position 2022 | 105B 76.29M 6.11B | Net cash position 2023 | 80.08B 58.22M 4.66B | EV / Sales 2023 | 2.04 x |
| P/E ratio 2022 |
-5.72
x | P/E ratio 2023 |
11.1
x | Employees | 174 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.99% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.32% | ||
| 1 week | +0.16% | ||
| Current month | -16.44% | ||
| 1 month | -23.65% | ||
| 3 months | +70.33% | ||
| 6 months | +101.95% | ||
| Current year | +67.57% |
1 week
6 120.00
6 650.00
1 month
5 830.007 980.00
Current year
3 325.009 410.00
1 year
2 865.009 410.00
3 years
2 865.0070 500.00
5 years
1 100.0070 500.00
10 years
1 100.0070 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Wan-Kyu Choi
CEO | Chief Executive Officer | 66 | 18/11/19 |
| Sales & Marketing | 54 | - | |
Jae-Myeong Yang
AUD | Comptroller/Controller/Auditor | 73 | 10/10/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wan-Kyu Choi
CEO | Chief Executive Officer | 66 | 18/11/19 |
Man-Seok Jo
BRD | Director/Board Member | 59 | 10/10/19 |
Seong-Won Hong
BRD | Director/Board Member | 73 | 10/10/19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 6,200 | +0.32% | 702,066 |
| 25/04/24 | 6,180 | -2.83% | 839,149 |
| 24/04/24 | 6,360 | 0.00% | 1,300,986 |
| 23/04/24 | 6,360 | 0.00% | 1,981,419 |
| 22/04/24 | 6,360 | +2.75% | 1,628,283 |
End-of-day quote Korea S.E., April 25, 2024
More quotes
BNC Korea Co. Ltd, formerly NH Special Purpose Acquisition 11 Co., Ltd., is a Korea-based company principally engaged in the manufacture and sale of biopharmaceuticals. The Company's main products include hyaluronic acid (HA) fillers, collagen wound dressings, antiadhesion materials and collagen tissue supplements, and others. In addition, the Company produces and sells cosmetics, medicines and medical devices, among others.
Sector
Pharmaceuticals
Calendar
12/05/2024
- Q1 2024 Earnings Release (Projected)
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +67.57% | 299M | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| -9.14% | 11.95B | |
| +5.24% | 8.71B | |
| -8.42% | 8.12B |
- Stock Market
- Equities
- A256840 Stock
